cbdMD (YCBD) Free Cash Flow (2016 - 2025)
cbdMD (YCBD) reported Free Cash Flow of -$977266.0 for Q4 2025, down 102.61% on a YoY basis from $37.4 million in Q4 2024, and down 301.25% sequentially from -$243553.0 in Q3 2025.
cbdMD (YCBD) Free Cash Flow (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Free Cash Flow data on file, last reported at -$977266.0 in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow fell 102.61% year-over-year to -$977266.0; the trailing twelve-month figure through Dec 2025 stood at -$2.1 million (down 190.14% YoY), and the FY2025 full-year result was -$1.6 million, down 201.5% from the prior year.
- Free Cash Flow eased to -$977266.0 in Q4 2025, from -$243553.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $289779.0 in Q2 2024 to a low of -$5.7 million in Q4 2021.
- A 5-year average of -$1.8 million and a median of -$841470.5 in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow sank 3122.64% in 2021 and jumped 184.49% in 2024, its largest moves.
- Tracing YCBD's Free Cash Flow over 5 years: stood at -$5.7 million in 2021, then surged by 60.67% to -$2.2 million in 2022, then jumped by 87.04% to -$290515.0 in 2023, then slumped by 66.03% to -$482336.0 in 2024, then plunged by 102.61% to -$977266.0 in 2025.
- Business Quant data shows YCBD's Free Cash Flow at -$977266.0 in Q4 2025, -$243553.0 in Q3 2025, and -$705675.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | -977,266.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -977,266.00 |
| Dec 31, 2025 | -977,266.00 |
| Sep 30, 2025 | -243,553.00 |
| Sep 30, 2025 | -243,553.00 |
| Jun 30, 2025 | -705,675.00 |
| Jun 30, 2025 | -705,675.00 |
| Mar 31, 2025 | -204,983.00 |
| Mar 31, 2025 | -204,983.00 |
| Dec 31, 2024 | -482,336.00 |
| Dec 31, 2024 | -482,336.00 |
| Sep 30, 2024 | 157,377.00 |
| Sep 30, 2024 | 157,377.00 |
| Jun 30, 2024 | 289,779.00 |
| Jun 30, 2024 | 289,779.00 |
| Mar 31, 2024 | -699,448.00 |
| Mar 31, 2024 | -699,448.00 |
| Dec 31, 2023 | -290,515.00 |
| Dec 31, 2023 | -290,515.00 |
| Sep 30, 2023 | -383,681.00 |
| Sep 30, 2023 | -383,681.00 |